BioSpace News Archive

Ng will further enable strategic engagements between biopharmaceutical and medical technology companies and health systems

New Safety and Tolerability Data to Be Presented From ALPINE Study of ARISTADA® and INVEGA SUSTENNA® in Patients With Schizophrenia

Invitae Corporation announced that Sean George, co-founder and chief executive officer of Invitae will present at the 2019 William Blair Growth Stock Conference on Wednesday, June 5, 2019 at 2:40 p.m. Central / 12:40 p.m. Pacific in Chicago.

The Mesothelioma Compensation Center is urging a person with recently diagnosed mesothelioma because of asbestos exposure at exposure at a public utility, water/sewer district, or any type of power plant to call them anytime at 800-714-0303 to make certain they talking directly with attorney Erik Karst and his amazing team at the law firm of Karst von Oiste to ensure the best possible financial compensation results-nationwide.

CollPlant, a regenerative medicine company, has launched a new HQ and R&D center in Israel.

The Warrants will have an exercise price of $3.45, will be exercisable upon issuance and will expire five years from the date of issuance.

Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States, announced its financial results for the quarter ending March 31, 2019, and provided an overview of recent operational highlights.

Announces 57 new customers in 2019 who have ditched the disk